Treadwell Therapeutics
VerifiedDeveloping novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including aneuploidy and immunogenicity. Learn more
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$364—546m (Dealroom.co estimates Nov 2021.)
New York City New York (HQ)
Deals in current and previous year:
Authorizing premium user...